Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nektar Therapeutics
Biotech
J&J vet jumps to Affinia—Chutes & Ladders
J&J vet jumps to Affinia. Astellas shakes up C-suite with exec firings. Pfizer builds oncology team with Legos.
Darren Incorvaia
,
Zoey Becker
Feb 7, 2025 8:30am
Nektar CEO slams Lilly's 'egregious error,' laments lost time
Aug 8, 2023 8:18pm
Nektar accuses Lilly of botching eczema clinical trial analysis
Aug 7, 2023 8:30am
Lilly hands rights to immunology med back to Nektar
Apr 27, 2023 9:14am
Nektar sticks with immunology, lays off 60% of SF workforce
Apr 18, 2023 7:00am
Lilly, Nektar stop lupus R&D, reassess eczema after phase 2 fail
Feb 24, 2023 6:52am